Literature DB >> 30527154

The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure.

Harun Kundi1, Jeffrey J Popma1, Linda R Valsdottir1, Changyu Shen1, Kamil F Faridi1, Duane S Pinto1, Robert W Yeh2.   

Abstract

BACKGROUND: We sought to identify nontraditional risk factors coded in administrative claims data and evaluate their ability to improve prediction of long-term mortality in patients undergoing percutaneous mitral valve repair.
METHODS: Patients undergoing transcatheter mitral valve repair using MitraClip implantation between September 28, 2010, and September 30, 2015 were identified among Medicare fee-for-service beneficiaries. We used nested Cox regression models to identify claims codes predictive of long-term mortality. Four groups of variables were introduced sequentially: cardiac and noncardiac risk factors, presentation characteristics, and nontraditional risk factors.
RESULTS: A total of 3782 patients from 280 clinical sites received treatment with MitraClip over the study period. During the follow-up period, 1114 (29.5%) patients died with a median follow-up time period of 13.6 (9.6 to 17.3) months. The discrimination of a model to predict long-term mortality including only cardiac risk factors was 0.58 (0.55 to 0.60). Model discrimination improved with the addition of noncardiac risk factors (c = 0.63, 0.61 to 0.65; integrated discrimination improvement [IDI] = 0.038, P < 0.001), and with the subsequent addition of presentation characteristics (c = 0.67, 0.65 to 0.69; IDI = 0.033, P < 0.001 compared with the second model). Finally, the addition of nontraditional risk factors significantly improved model discrimination (c = 0.70, 0.68 to 0.72; IDI = 0.019, P < 0.001, compared with the third model).
CONCLUSIONS: Risk-prediction models, which include nontraditional risk factors as identified in claims data, can be used to predict long-term mortality risk more accurately in patients who have undergone MitraClip procedures.
Copyright © 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30527154      PMCID: PMC6424362          DOI: 10.1016/j.cjca.2018.10.002

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  28 in total

1.  A method for checking regression models in survival analysis based on the risk score.

Authors:  J K Grønnesby; O Borgan
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

2.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

3.  Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair.

Authors:  Clemens Metze; Anna-Sophie Matzik; Maximilian Scherner; Maria Isabel Körber; Guido Michels; Stephan Baldus; Volker Rudolph; Roman Pfister
Journal:  JACC Cardiovasc Interv       Date:  2017-10-09       Impact factor: 11.195

4.  A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation.

Authors:  Sergio Buccheri; Davide Capodanno; Marco Barbanti; Antonio Popolo Rubbio; Maria Elena Di Salvo; Salvatore Scandura; Sarah Mangiafico; Giuseppe Ronsivalle; Marta Chiarandà; Piera Capranzano; Carmelo Grasso; Corrado Tamburino
Journal:  Am J Cardiol       Date:  2017-02-10       Impact factor: 2.778

5.  Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment.

Authors:  H M Krumholz; J Chen; Y Wang; M J Radford; Y T Chen; T A Marciniak
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

6.  Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata.

Authors:  Liliya Paranskaya; Giuseppe D'Ancona; Ilkay Bozdag-Turan; Ibrahim Akin; Stephan Kische; Gökmen R Turan; Dimitar Divchev; Tim C Rehders; Henrik Schneider; Jasmin Ortak; Christoph A Nienaber; Hüseyin Ince
Journal:  EuroIntervention       Date:  2012-09       Impact factor: 6.534

7.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.

Authors:  Bernard Iung; Gabriel Baron; Eric G Butchart; François Delahaye; Christa Gohlke-Bärwolf; Olaf W Levang; Pilar Tornos; Jean-Louis Vanoverschelde; Frank Vermeer; Eric Boersma; Philippe Ravaud; Alec Vahanian
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

8.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Authors:  Gregg W Stone; JoAnn Lindenfeld; William T Abraham; Saibal Kar; D Scott Lim; Jacob M Mishell; Brian Whisenant; Paul A Grayburn; Michael Rinaldi; Samir R Kapadia; Vivek Rajagopal; Ian J Sarembock; Andreas Brieke; Steven O Marx; David J Cohen; Neil J Weissman; Michael J Mack
Journal:  N Engl J Med       Date:  2018-09-23       Impact factor: 91.245

9.  Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial.

Authors:  Hermann Reichenspurner; Wolfgang Schillinger; Stephan Baldus; Jörg Hausleiter; Christian Butter; Ulrich Schäefer; Giovanni Pedrazzini; Francesco Maisano
Journal:  Eur J Cardiothorac Surg       Date:  2013-07-17       Impact factor: 4.191

10.  One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry.

Authors:  Miriam Puls; Edith Lubos; Peter Boekstegers; Ralph Stephan von Bardeleben; Taoufik Ouarrak; Christian Butter; Christine S Zuern; Raffi Bekeredjian; Horst Sievert; Georg Nickenig; Holger Eggebrecht; Jochen Senges; Wolfgang Schillinger
Journal:  Eur Heart J       Date:  2015-11-27       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.